Botulinum toxin for treatment of primary chronic headache disorders

BlueCross BlueShield Association
Record ID 32003000749
Authors' objectives:

This Assessment will evaluate whether or not the addition of botulinum toxin injections to patients usual regimens of prophylactic and/or abortive drug therapy improves outcomes in patients with primary chronic headache syndromes who have significant disability due to headaches despite of conventional pharmacologic treatment.

Authors' methods: Systematic review
Project Status: Completed
Year Published: 2002
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Botulinum Toxins
  • Headache
  • Headache Disorders
Organisation Name: BlueCross BlueShield Association
Contact Address: BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
Contact Email:
Copyright: BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.